Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Hyve Group plc

16 Mar 2023 14:10

RNS Number : 2599T
Odyssean Investment Trust PLC
16 March 2023
 

FORM 8.3

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Odyssean Investment Trust PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Same as 1(a)

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Hyve Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

15 March 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary share

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0%

N/A

N/A

(2) Cash-settled derivatives:

 

N/A

N/A

N/A

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

N/A

N/A

N/A

TOTAL:

 

0

0%

N/A

N/A

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary share

Sale

6,676,437

111.2996 pence

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

16 March 2023

Contact name:

Mark Pope, on behalf of Frostrow Capital LLP - Company Secretary

 

Telephone number*:

0203 008 4913

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETFLFISVAIRLIV
Date   Source Headline
12th Apr 20123:11 pmRNSBlocklisting Interim Review
12th Apr 20127:00 amRNSAcquisition of Beautex
4th Apr 20121:15 pmRNSHolding(s) in Company
2nd Apr 201211:45 amRNSTotal Voting Rights
23rd Mar 20129:00 amRNSChange of Chairman
22nd Feb 20127:00 amRNSAnnual Information Update
17th Feb 20126:20 pmRNSHolding(s) in Company (Replacement)
17th Feb 20126:10 pmRNSHolding(s) in Company
2nd Feb 20123:47 pmRNSDirector/PDMR Shareholding
1st Feb 20125:49 pmRNSTotal Voting Rights
1st Feb 20121:38 pmRNSDirector/PDMR Shareholding
30th Jan 20123:42 pmRNSDirector/PDMR Shareholding
26th Jan 201212:43 pmRNSAppointment of Chairman Designate
26th Jan 201212:43 pmRNSResult of AGM
26th Jan 20127:00 amRNSInterim Management Statement
12th Jan 20124:12 pmRNSDirector/PDMR Shareholding
21st Dec 20113:46 pmRNSHolding(s) in Company
20th Dec 20114:06 pmRNSAnnual Financial Report
5th Dec 201111:21 amRNSDirector/PDMR Shareholding
29th Nov 20117:00 amRNSPreliminary Results Announcement
28th Nov 20117:00 amRNSAcquisition of Autoexpo
23rd Nov 20113:26 pmRNSHolding(s) in Company
6th Oct 20113:55 pmRNSHolding(s) in Company
3rd Oct 20117:00 amRNSPre-close Trading Update
14th Sep 20114:03 pmRNSHolding(s) in Company
19th Jul 20117:00 amRNSInterim Management Statement
13th Jul 20117:00 amRNSAcquisition
12th Jul 20111:24 pmRNSHolding(s) in Company
8th Jul 201110:35 amRNSDirector/PDMR Shareholding
7th Jul 201110:22 amRNSDirector Appointment
1st Jul 20118:25 amRNSDirector Declaration
24th Jun 20113:47 pmRNSHolding(s) in Company
9th Jun 201112:59 pmRNSDirectorate Change
7th Jun 20119:59 amRNSHolding(s) in Company
3rd Jun 20115:19 pmRNSInterim Report 2011
25th May 20119:40 amRNSDirector/PDMR Shareholding
16th May 20111:13 pmRNSDirector/PDMR Shareholding
16th May 201110:58 amRNSDividend Declaration
16th May 20117:00 amRNSInterim Results
12th May 20111:22 pmRNSHolding(s) in Company
5th May 20114:24 pmRNSHolding(s) in Company
3rd May 20112:42 pmRNSNotice of Results
13th Apr 20114:28 pmRNSHolding(s) in Company
28th Mar 20112:44 pmRNSHolding(s) in Company
25th Mar 201111:48 amRNSDirector/PDMR Shareholding
11th Mar 20114:21 pmRNSDirector/PDMR Shareholding
3rd Mar 20117:00 amRNSAcquisition
1st Mar 201111:14 amRNSTotal Voting Rights
24th Feb 20113:10 pmRNSHolding(s) in Company
22nd Feb 20111:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.